Nuveen
ARKG icon

Nuveen’s ARK Genomic Revolution ETF ARKG Stock Holding History

Nuveen’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.4K Buy
+100
New +$4.5K ﹤0.01% 4664

Other funds holding ARKG

Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Florin Court Capital
Florin Court Capital London, United Kingdom $97M AUM 40.08% 1-Year Est. Return
NTV Asset Management
NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return
Midwest Financial Partners Investments
Midwest Financial Partners Investments St. Cloud, Minnesota $260M AUM 10.89% 1-Year Est. Return
Canal Insurance Company
Canal Insurance Company Greenville, South Carolina $426M AUM 30.47% 1-Year Est. Return
Gimbal Financial
Gimbal Financial Carmel, Indiana $172M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Nuveen's ARKG Position: Q3 2026 in Review

Nuveen opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2026: 100 shares worth $5.4K. The stake represents ﹤0.01% of the portfolio and ranks #4664 among its holdings.

184 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • Nuveen held 100 shares of ARK Genomic Revolution ETF worth $5.4K as of Q3 2026.
  • ARK Genomic Revolution ETF was a new Nuveen position in Q3 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4664 holding.
  • 184 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.